Study on the Pharmacokinetics and Safety of QL1012D and Gonal-F® in Healthy Female Volunteers
Clinical trial NCT06864793 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06864793
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-06
- Primary completion
- 2026-02-04
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.